Trial Information
Inclusion Criteria:
- Adult (≥18 years) patients with (any type and any stage of) cancer who were
undergoing chemotherapy treatment in an ambulatory setting or during short hospital
stays
- Dutch speaking
- Able to provide informed consent and to participate in an interview
Exclusion Criteria:
- Patients who were in the first 2 cycles of treatment
- Patients for whom an interview was considered physically, mentally and/or emotionally
too burdensome.
- Patients who had reported not to experience any side effect from treatment at all
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
patient's experience
Outcome Time Frame:
one interview during the course of treatment, i.e. one timepoint between 2 months after the start of chemotherapy and the end of the patient's treatment
Safety Issue:
No
Authority:
Belgium: The Federal Public Service (FPS) Health, Food Chain Safety and Environment
Study ID:
B322201214929
NCT ID:
NCT01867489
Start Date:
September 2012
Completion Date:
Related Keywords:
- Exploration of How Patients Deal With Side Effects From Chemotherapy